AB
ROIV icon

Amalgamated Bank’s Roivant Sciences ROIV Stock Holding History

Amalgamated Bank’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.14M Buy
201,824
+1,372
+0.7% +$40.5K 0.05% 304
2026
Q1 		$5.55M Buy
200,452
+10,648
+6% +$274K 0.04% 379
2025
Q4 		$4.12M Sell
189,804
-4,882
-3% -$96.3K 0.03% 499
2025
Q3 		$2.95M Buy
194,686
+4,716
+2% +$58.4K 0.02% 648
2025
Q2 		$2.14M Sell
189,970
-2,673
-1% -$29K 0.02% 768
2025
Q1 		$1.94M Sell
192,643
-11,678
-6% -$126K 0.02% 781
2024
Q4 		$2.42M Sell
204,321
-3,165
-2% -$37.4K 0.02% 727
2024
Q3 		$2.39M Buy
207,486
+11,358
+6% +$129K 0.02% 736
2024
Q2 		$2.07M Buy
196,128
+4,394
+2% +$48.2K 0.02% 823
2024
Q1 		$2.02M Buy
191,734
+121,426
+173% +$1.31M 0.02% 852
2023
Q4 		$790K Sell
70,308
-346
-0.5% -$3.37K 0.01% 1252
2023
Q3 		$825K Buy
70,654
+18,543
+36% +$210K 0.01% 1191
2023
Q2 		$525K Buy
+52,111
New +$466K ﹤0.01% 1412

Other funds holding ROIV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PDM
Penn Davis McFarland Dallas, Texas $1.12B AUM 32.35% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Amalgamated Bank's ROIV Position: Q2 2026 in Review

Amalgamated Bank increased its Roivant Sciences (ROIV) stake by 0.68% in Q2 2026, buying an estimated $40.5K and bringing the position to 201,824 shares worth $7.14M. The position accounts for 0.05% of the portfolio, ranked #304.

Amalgamated Bank first reported a position in ROIV in Q2 2023 and has held it in 13 quarters since. 232 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Amalgamated Bank held 201,824 shares of Roivant Sciences worth $7.14M as of Q2 2026.
  • Amalgamated Bank bought 1,372 Roivant Sciences shares in Q2 2026, an estimated $40.5K.
  • Roivant Sciences made up 0.05% of Amalgamated Bank's portfolio in Q2 2026, its #304 holding.
  • Amalgamated Bank first reported a position in Roivant Sciences in Q2 2023 and has held it in 13 quarters since.
  • 232 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.